Bradley Campbell was appointed President and CEO of Amicus Therapeutics on July 31, 2025.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bradley Campbell was appointed President and CEO of Amicus Therapeutics on July 31, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bradley Campbell
researcher
Nothing else this week.
-
Amicus Therapeutics
company in Cranbury, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireAmicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates Q2 2025 Total Revenue of $154.7M, up 18% at CER Galafold® Q2 Revenue of $128.9M, up 12% at CER Pombiliti® + O